Human Health Holdings Ltd

Chart & Performance

D1W1MN

P/E

11.77

P/S

0.48

EPS

0.06

Div Yield, %

21.33%

Shrs. gr., 5y

0.43%

Rev. gr., 5y

2.25%

Revenues

591m

-41.02%

Net income

24m

-86.62%

CFO

11m

-98.29%

Dividend

Dec 04, 20240.028 HKD/sh

Profile

Human Health Holdings Limited, an investment holding company, provides healthcare services in Hong Kong. The company offers general practice services, including general consultation, diagnostics and preventative health, minor procedure, vaccination, physical check-up, health education, occupational health advisory, Chinese medicine, work injury assessment, telemedicine, COVID-19 related, outreach services, and healthcare related services and products. It also provides specialty services in the areas of general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology, as well as physiotherapy, clinical psychology, medical aesthetics, nutritionist, health and wellness, endoscopy, and medical diagnostics. In addition, the company offers dental services comprising general dentistry, dental implant, 3D guided implant surgery, crown and bridge, periodontal treatment, prosthodontics, oral surgery, orthodontics, endodontics, cosmetic dentistry, teeth whitening, veneers and laser dentistry, advanced oral and maxillofacial surgery, CAD/CAM dentistry, panoramic radiography, and cone-beam computed tomography services. Further, it provides doctors and dentists agreements management, and medical imaging services. As of June 30, 2021, the company operated 58 medical centers and 103 service points. The company was founded in 1997 and is headquartered in Kowloon, Hong Kong. Human Health Holdings Limited is a subsidiary of Treasure Group Global Limited.

URL

https://humanhealth.com.hk/zh-hant/

IPO date

Apr 01, 2016

Employees

541

Domiciled in

Incorporated in

Valuation

Order:

Title HKD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title HKD in thousands, except ratios and share amounts	2024‑06	2023‑06	2022‑06	2021‑06	2020‑06	2019‑06	2018‑06	2017‑06	2016‑06	2015‑06
Income
Revenues	590,819 -41.02%	1,001,746 -10.70%	1,121,793 71.34%
Cost of revenue	504,663	619,883	629,910
Unusual Expense (Income)
NOPBT	86,156	381,863	491,883
NOPBT Margin	14.58%	38.12%	43.85%
Operating Taxes	2,375	57,977	69,953
Tax Rate	2.76%	15.18%	14.22%
NOPAT	83,781	323,886	421,930
Net income	24,189 -86.62%	180,839 -51.82%	375,309 159.81%
Dividends	(60,728)	(113,863)	(45,546)
Dividend yield	15.69%	15.79%	7.36%
Proceeds from repurchase of equity
BB yield
Debt
Debt current	80,564	84,641	81,464
Long-term debt	180,814	195,700	214,012
Deferred revenue		(1)
Other long-term liabilities	7,562	7,620	7,681
Net debt	(345,265)	(467,517)	(70,441)
Cash flow
Cash from operating activities	11,342	664,264	295,814
CAPEX	(39,508)	(84,023)	(76,516)
Cash from investing activities	(47,635)	(335,344)	(203,219)
Cash from financing activities	(122,658)	(178,285)	(67,447)
FCF	99,221	568,371	142,060
Balance
Cash	489,583	641,257	270,332
Long term investments	117,060	106,601	95,585
Excess cash	577,102	697,771	309,827
Stockholders' equity	576,445	617,996	551,725
Invested Capital	344,243	281,707	532,093
ROIC	26.77%	79.60%	108.06%
ROCE	9.35%	42.41%	58.36%
EV
Common stock shares outstanding	379,552	379,552	379,552
Price	1.02 -46.32%	1.90 16.56%	1.63 63.00%
Market cap	387,143 -46.32%	721,149 16.56%	618,670 63.00%
EV	41,878	253,632	548,229
EBITDA	154,165	456,653	554,957
EV/EBITDA	0.27	0.56	0.99
Interest	8,220	8,102	2,934
Interest/NOPBT	9.54%	2.12%	0.60%